- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.01. | Cordlife renews cord blood and human tissue banking licences | 2 | Singapore Business Review | ||
| CORDLIFE GROUP Aktie jetzt für 0€ handeln | |||||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RENEWAL OF LICENCES | 1 | SGX Company Announcements | ||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 04.12.25 | Cordlife faces $5.45m in claims over 109 damaged cord blood units | 2 | Singapore Business Review | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-INDEPENDENT NON-EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 4 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RECEIPT OF NOTICE OF REGULATORY ACTION | 2 | SGX Company Announcements | ||
| 27.11.25 | Health ministry suspends Cordlife's blood banking license | 3 | Singapore Business Review | ||
| 27.11.25 | CORDLIFE GROUP LIMITED: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: REPL::FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CESSATION OF EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 27.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::SUBMISSION OF WRITTEN REPRESENTATIONS TO MOH | 2 | SGX Company Announcements | ||
| 21.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CLARIFICATION TO CERTAIN MEDIA REPORTS | 1 | SGX Company Announcements | ||
| 13.10.25 | Cordlife granted extension to appeal license suspension | 2 | Singapore Business Review | ||
| 13.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF TIME GRANTED BY MOH TO PROVIDE WRITTEN REPRESENTATIONS | 1 | SGX Company Announcements | ||
| 07.10.25 | Cordlife assures continuity of operations amidst possible licence suspension | 7 | Singapore Business Review |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| Q&M DENTAL | 0,200 | -1,96 % | Q & M DENTAL GROUP (SINGAPORE) LIMITED: CHANGE - CHANGE IN CORPORATE INFORMATION::CHANGE OF REGISTERED OFFICE ADDRESS | ||
| SDI LIMITED | - | - | SDI LIMITED: Trading Update December 2025 | ||
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Novo Nordisk gegen Hims & Hers: 49-Dollar-Angriff auf den Abnehm-Boom: Warum Novo Nordisk jetzt vor Gericht zieht | Der Markt für Abnehmmedikamente steht vor einer neuen Belastungsprobe. Eine günstigere Alternative zur bekannten Gewichtsreduktionspille sorgt für erhebliche Unruhe in der Branche und verschärft den... ► Artikel lesen |
Das Unternehmen CORDLIFE GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORDLIFE GROUP LIMITED finden Sie auf Wallstreet Online.